Detalles de la búsqueda
1.
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
BMC Cancer
; 21(1): 851, 2021 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301221
2.
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.
Cancer
; 125(1): 99-108, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30332497
3.
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-ß signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors.
Cell Death Dis
; 14(2): 93, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765032
4.
JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues.
Virchows Arch
; 465(6): 715-22, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25280461
Resultados
1 -
4
de 4
1
Próxima >
>>